Aura Biosciences, Inc. (NASDAQ:AURA)
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$131.0M
- Net margin
- —
Little or no net debt.
- Total debt
- $16.6M
- Cash
- $67.8M
- Debt / equity
- 0.05
Comfortably covers what is due within a year.
- Current assets
- $329.0M
- Current liabilities
- $19.6M
- Current ratio
- 16.82
Consumes cash and must keep raising it.
- Operating cash flow
- -$102.3M
- Free cash flow
- -$102.7M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 94.9M
- Share growth (1y)
- 63.5%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
AURA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 300.00 K | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | -300.00 K | 0.00 |
| SG&A Expense | 17.32 M | 6.91 M | 5.34 M | 5.73 M | 5.73 M | 5.69 M |
| R&D Expense | 30.75 M | 27.96 M | 21.90 M | 22.18 M | 22.88 M | 23.34 M |
| Operating Expenses | 48.07 M | 34.87 M | 27.24 M | 27.91 M | 28.31 M | 29.04 M |
| Operating Income | -48.07 M | -34.87 M | -27.24 M | -27.91 M | -28.61 M | -29.04 M |
| Pretax Income | -45.61 M | -33.67 M | -25.54 M | -26.10 M | -26.97 M | -27.46 M |
| Tax Provision | 29.00 K | 11.00 K | 15.00 K | 26.00 K | 48.00 K | 18.00 K |
| Net Income | -45.64 M | -33.69 M | -25.56 M | -26.13 M | -27.02 M | -27.48 M |
| EPS (Basic) | -0.48 | -0.50 | -0.40 | -0.40 | -0.47 | -0.55 |
| EPS (Diluted) | -0.48 | -0.50 | -0.40 | -0.40 | -0.47 | -0.55 |
| Shares Outstanding | 94.86 M | 67.45 M | 60.34 M | 65.94 M | 58.02 M | 50.13 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.